FDA Adverse Event Injury Summary report: N

GUIDEWIRE MODEL UNKNOWN

MDR report key: 4714175 · Received April 21, 2015

Report

Report Number
2029214-2015-00407
Event Type
Injury
Date Received
April 21, 2015
Date of Event
April 12, 2008
Report Date
March 25, 2015
Manufacturer
COVIDIEN (IRVINE)
Product Code
DQX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

HTTP://WWW.NCBI.NLM.NIH.GOV/PUBMED/18408923.THIS REPORT WAS CREATED TO CAPTURE THE EVENTS RELATED TO THE UNKNOWN GUIDEWIRE. THE GUIDEWIRE WAS NOT RETURNED FOR ANALYSIS; THEREFORE, THE EVENT CAUSE COULD NOT BE DETERMINED. THE LOT HISTORY RECORD REVIEW WAS NOT POSSIBLE SINCE THE LOT NUMBER WAS NOT REPORTED. (B)(4).

Description of Event or Problem · 1

CITATION: VASILIOS KATSARIDIS ET AL. CURATIVE EMBOLIZATION OF CEREBRAL ARTERIOVENOUS MALFORMATIONS (AVMS) WITH ONYX IN 101 PATIENTS. NEURORADIOLOGY (2008) 50:589¿597. DOI 10.1007/S00234-008-0382-X. THE FOLLOWING REPORT WAS RECEIVED BY MEDTRONIC THROUGH LITERATURE REVIEW: PATIENTS WHO WERE TREATED WITH ONYX EMBOLIZATION FOR A BRAIN ARTERIOVENOUS MALFORMATIONS (AVM) FROM 1 JANUARY 2004 TO 31 DECEMBER 2007 (4 YEARS). 101 PATIENTS WERE IDENTIFIED (43 WOMEN, 58 MEN; MEAN AGE 38.8 YEARS; AGE RANGE (14-65). ONE PATIENT (1/101, 0.5%) HAD A SEVERE INTRA-PARENCHYMAL HEMORRHAGE IN THE OCCIPITAL LOBE DUE TO THE PERFORATION OF A FEEDING ARTERY BY THE GUIDE-WIRE AND WAS TREATED BY SURGICAL REMOVAL OF BOTH THE HEMATOMA AND THE MALFORMATION; THIS PATIENT SUBSEQUENTLY HAD AN EXCELLENT RECOVERY. PROCEDURE WAS PERFORMED WITH A COMBINATION OF THE FLOW-GUIDED AND THE WIRE-GUIDED TECHNIQUES USING 0.010 INCH OR A 0.008 INCH WIRE (SILVERSPEED OR MIRAGE). IT IS UNKNOWN WHICH WAS USED IN THIS EVENT. INFORMATION RECEIVED FROM THE SAME ARTICLE AS MFR#S: 2029214-2015-00362, 2029214-2015-00363, 2029214-2015-00402, 2029214-2015-00408.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
264674 GUIDEWIRE MODEL UNKNOWN GUIDEWIRE, CATHETER DQX COVIDIEN (IRVINE)

Patients

Seq Age Sex Outcome Treatment
1 39 YR Other| R